{"id":135960,"date":"2024-06-10T12:25:01","date_gmt":"2024-06-10T16:25:01","guid":{"rendered":"https:\/\/ccs.ca\/?post_type=news&p=135960"},"modified":"2024-06-10T14:28:13","modified_gmt":"2024-06-10T18:28:13","slug":"ccs-and-cwhha-partner-on-clinical-practice-update-on-minoca","status":"publish","type":"news","link":"https:\/\/ccs.ca\/news\/ccs-and-cwhha-partner-on-clinical-practice-update-on-minoca\/","title":{"rendered":"CCS and CWHHA Partner on Clinical Practice Update on MINOCA\u00a0"},"content":{"rendered":"\n

Myocardial Infarction with No Obstructive Coronary Artery Disease (MINOCA) can be an invisible diagnosis to many clinicians. And by being invisible, it is often untreated. MINOCA represents 6%-15% of all acute coronary syndromes, with women disproportionately represented and likely undiagnosed.\u202f\u202f <\/p>\n\n\n\n

A persistent gap in clinical outcomes is observed in women diagnosed with\u202fmyocardial infarction (MI), including:\u202f\u00a0\u00a0<\/p>\n\n\n\n